2 results
Approved WMORecruiting
The primary objective of this study is to observe the long-term efficacy, safety, and tolerability of repeated administration of Upadacitinib (ABT-494) in subjects with Crohn's disease (CD) who completed Study M13-740.
Approved WMORecruiting
To evaluate the Long-Term Safety and Efficacy of upadacitinib.